Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Dosing Strategies for Postanesthesia Recovery in Gynecologic Laparoscopy
ChiCTR2500112176Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Anesthesia-related recovery impairment (ARRI), postoperative pain, Postoperative sleep disturbance (PSD) and 1 more (3 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoint: Recovery time of consciousness. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Anesthesia-related recovery impairment (ARRI)postoperative painPostoperative sleep disturbance (PSD)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500112176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112176.